SEC EDGAR published this disclosure on 2026-07-16. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001809519-26-000137
acquired disposedA
codeM
direct or indirectD
form4
is derivativefalse
issuer nameGoodRx Holdings, Inc.
labelExercise of derivative
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001809519-26-000137",
"acquired_disposed": "A",
"code": "M",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "GoodRx Holdings, Inc.",
"label": "Exercise of derivative",
"person_name": "Barnes Wendy Lynn",
"price": null,
"role": "Director, See Remarks",
"security": "Class A Common Stock",
"shares": 110963,
"shares_owned_after": 789860,
"source_path": "edgar/data/2049585/0001809519-26-000137.txt",
"ticker": "GDRX",
"value": null
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.